News & Information

Boditech Med Inc.

July 16, 2017

Boditech Med Inc [KOSDAQ A206640] announced to acquire the stocks of Ugenecell Inc. Boditech has been developing products for in-vitro diagnostics and diagnostic reagents for the past 20 years by pursuing the value of a company called "Respect for Life". Now, Boditech is the main stockholder of Ugenecell.


February 09, 2017

Can your remember we've met at Dubai?

Ugenecell Inc. participated MEDLAB ME 2017 held at Dubai International Exhibition Centre United Arab Emirates from 6th to 9th February 2017. The prototype of ExAmplar and kits were demonstrated. 

Please reload